Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Dasatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Breast Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 11 Leukemia, Myeloid, Chronic-Phase 10 Prostatic Neoplasms 8 Recurrence 6 Lung Neoplasms 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Burkitt Lymphoma 5 Melanoma 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Gliosarcoma 3 Blast Crisis 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02750514 2021-03-22

FRACTION-Lung

Bristol-Myers Squibb

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡